Skip to main content

Table 2 General characteristics of the participants for in vivo efficacy studies by region

From: Delayed Plasmodium falciparum clearance following artesunate-mefloquine combination therapy in Thailand, 1997–2007

   Total East West p-value*
Age mean (95% CI) 31.6 (30.8, 32.3) 35.2 (33.9, 36.5) 30.0 (29.1, 30.9) p < 0.001
  range (5, 80) (8, 74) (5, 80)  
  missing 61 7 54  
Weight (kg) mean (95% CI) 52.9 (52.3, 53.5) 55.2 (53.9, 56.4) 52.3 (51.6, 53.0) p < 0.001
  range (15, 92) (18, 85) (15, 92)  
  missing 223 164 59  
Initial parasite geometric mean (95% CI) 17998 (16861, 19135) 20478 (18189, 22766) 16958 (15663, 18253) p = 0.007
density range (520, 116960) (560, 116000) (520, 116960)  
  missing 0 0 0  
Sex male (%) 1071 (81.1) 334 (85.2) 737 (79.4) p = 0.014
  female (%) 249 (18.9) 58 (14.8) 191 (20.6)  
  missing 7 0 7  
  1. Abbreviations: OR, odds ratio; CI, confidence interval.
  2. *Results of t-tests (age, weight, and initial parasite density) and chi-square test (sex). Both age and parasite density was natural logarithm transformed.